Clottafact

Clottafact is a human fibrinogen product used to manage bleeding disorders. This intravenous medication supports blood clotting and is manufactured by Lfb Biomedicaments in the EU.

Clottafact is primarily used to treat bleeding disorders where fibrinogen levels are low. It helps in the formation of blood clots, which is essential for controlling bleeding. This medication is often used in situations where natural clotting mechanisms are impaired, such as in certain genetic disorders or after trauma.

Clottafact works by providing fibrinogen, a protein that plays a crucial role in blood clotting. When administered intravenously, it helps to form clots at the site of injury, thereby reducing bleeding. The effects are typically observed soon after administration, supporting the body's natural clotting process.

Clottafact should be handled with care and administered under medical supervision. It is important to follow proper storage and handling guidelines to maintain its effectiveness. Patients should inform their healthcare provider about any allergies or medical conditions before using this medication.

Clottafact may interact with other medications that affect blood clotting. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Additionally, certain substances, such as alcohol, may affect the body's clotting mechanisms and should be used with caution.